Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
Pediatric Terrorism and Disaster Preparedness

Public Health Emergency Preparedness

This resource was part of AHRQ's Public Health Emergency Preparedness program, which was discontinued on June 30, 2011, in a realignment of Federal efforts.

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 4.5. Postexposure Prophylaxis for Anthrax

Patient Prophylactic Treatment
Adults (including pregnant women and immunocompromised people) Ciprofloxacin 500 mg, PO, BID 60 days or Doxycycline 100 mg, PO, BID 60 days
Children Ciprofloxacin 10-5 mg/kg, PO, BID 60 days (total daily dose not to exceed 1000 mg) or Doxycycline at:
  • >8 yr and >45 kg: 100 mg, PO, BID 60 days.
  • >8 yr and <45 kg: 2.2 mg/kg, PO, BID 60 days.
  • 8 yr or younger: 2.2 mg/kg, PO, BID 60 days.

Notes: BID = twice a day; PO = by mouth.

Return to Document

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care